— Know what they know.
Not Investment Advice
Also trades as: 0LJL.L (LSE) · $vol 0M · UHID (OTC) · $vol 0M

UHS NYSE

Universal Health Services, Inc.
1W: -4.4% 1M: +0.0% 3M: +5.5% YTD: -19.2% 1Y: -15.7% 3Y: +43.7% 5Y: +37.2%
$177.32
-8.39 (-4.52%)
 
Weekly Expected Move ±3.2%
$175 $181 $187 $193 $199
NYSE · Healthcare · Medical - Care Facilities · Tech Score Neutral · Power 59 · $9.2B mcap · 49M float · 1.60% daily turnover · Short 56% of daily vol
Credit Risk of going bust: lower than 59% of companies Debt: 32.5% of company value Bonds: $175.9M held by 199 funds, 105 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $5.92 (down 97%), Universal Health Services, Inc. would be worth roughly what it owes.
Total debt $5.26B against a stock market value of $10.95B.
Distance to default 6.09 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.81B (short-term plus half of long-term), stock volatility 32.5%; Altman Z'' 3.72. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
65.9 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 12.5%  ·  5Y Avg: 9.5%
Cost Advantage
57
Intangibles
79
Switching Cost
67
Network Effect
67
Scale
53
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. UHS has a Narrow competitive edge (65.9/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Intangible Assets. ROIC of 12.5% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$197
Avg Target
$223
High
Based on 29 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 17Hold: 25Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$196.71
Analysts7
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-03 RBC Capital Ben Hendrix $190 $183 -7 +6.5% $171.80
2026-07-30 Goldman Sachs — $219 $190 -29 +13.0% $168.16
2026-07-29 UBS — $310 $290 -20 +74.5% $166.22
2026-07-29 Guggenheim Jason Cassorla $195 $189 -6 +13.7% $166.22
2026-07-29 Robert W. Baird — $204 $166 -38 -0.1% $166.22
2026-07-29 Morgan Stanley Craig Hettenbach $233 $191 -42 +14.9% $166.22
2026-07-28 Barclays — $179 $168 -11 +5.5% $159.31
2026-07-20 Guggenheim — $211 $195 -16 +29.0% $151.16
2026-07-13 Wells Fargo — $165 $166 +1 +6.7% $155.57
2026-07-08 Barclays — $238 $179 -59 +11.0% $161.26
2026-06-01 Wells Fargo — $235 $165 -70 +12.9% $146.11
2026-04-30 UBS — $245 $310 +65 +84.7% $167.86
2026-04-29 Cantor Fitzgerald — Initiated $194 — +15.8% $167.51
2026-04-29 RBC Capital — $231 $190 -41 +16.9% $162.54
2026-04-29 Guggenheim — $274 $211 -63 +29.8% $162.54
2026-04-29 Robert W. Baird Michael Ha $203 $204 +1 +25.5% $162.54
2026-04-28 Barclays — $262 $238 -24 +32.6% $179.51
2026-01-22 Barclays — $263 $262 -1 +28.6% $203.68
2026-01-07 UBS — $231 $245 +14 +14.0% $214.97
2026-01-07 Wells Fargo — $249 $235 -14 +6.0% $221.74
2025-12-02 Guggenheim Jason Cassorla $253 $274 +21 +14.4% $239.43
2025-11-03 Raymond James John Ransom $219 $270 +51 +24.4% $217.01
2025-10-30 UBS — $302 $231 -71 +2.5% $225.30
2025-10-30 RBC Capital Ben Hendrix $189 $231 +42 +3.3% $223.61
2025-10-29 UBS — $227 $302 +75 +37.7% $219.32
2025-10-29 Guggenheim Jason Cassorla Initiated $253 — +15.4% $219.32
2025-10-29 Morgan Stanley Craig Hettenbach $200 $233 +33 +6.2% $219.32
2025-10-28 Barclays — $256 $263 +7 +22.9% $214.03
2025-10-28 Mizuho Securities Ann Hynes $153 $242 +89 +13.1% $214.03
2025-10-14 Goldman Sachs — $135 $219 +84 +10.7% $197.76
2025-10-07 Wells Fargo — $154 $249 +95 +19.1% $209.11
2025-08-14 Robert W. Baird Michael Ha $274 $203 -71 +14.1% $177.91
2025-07-30 UBS — $226 $227 +1 +37.2% $165.44
2025-03-26 Morgan Stanley — Initiated $200 — +8.4% $184.46
2024-09-04 Robert W. Baird Michael Ha $236 $274 +38 +15.9% $236.47
2024-07-26 Raymond James Sarah James Initiated $219 — +6.8% $204.99
2024-07-26 Barclays Andrew Mok $142 $256 +114 +21.5% $210.68
2024-06-26 Robert W. Baird Michael Ha Initiated $236 — +25.7% $187.70
2024-06-05 HSBC Sidharth Sahoo Initiated $580 — +517.0% $94.00
2024-05-19 UBS AJ Rice Initiated $226 — +27.2% $177.70
2024-05-07 RBC Capital Frank Morgan $130 $189 +59 +11.7% $169.15
2024-04-12 Deutsche Bank Pito Chickering Initiated $203 — +20.5% $168.40
2024-04-01 Stephens Scott Fidel $135 $185 +50 +1.4% $182.46
2023-04-24 Barclays Steven Valiquette $132 $142 +10 +0.9% $140.70
2023-01-09 Barclays — Initiated $132 — -13.3% $152.21
2023-01-03 Wells Fargo Stephen Baxter $118 $154 +36 +8.4% $142.03
2022-07-01 Credit Suisse — $158 $141 -17 +37.9% $102.23
2022-05-03 Mizuho Securities — $290 $153 -137 +22.4% $124.98
2022-04-28 Wells Fargo — Initiated $118 — -5.0% $124.16
2022-04-27 Stephens — $142 $135 -7 +8.6% $124.31

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
Oct 27, 2026
DCF
4
ROE
5
ROA
5
D/E
1
P/E
4
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. UHS receives an overall rating of A. Strongest factors: DCF (4/5), ROE (5/5), ROA (5/5), P/E (4/5), P/B (4/5). Areas of concern: D/E (1/5).
Rating Change History
DateFromTo
2026-07-29 A- A
2026-07-28 A A-
2026-04-30 B A
2026-04-28 A B
2026-04-27 A- A

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 61 Grade A
Profitability
60
Balance Sheet
61
Earnings Quality
79
Growth
63
Value
88
Momentum
86
Safety
65
Cash Flow
40
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. UHS scores highest in Value (88/100) and lowest in Cash Flow (40/100). An overall grade of A places UHS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.99
Grey Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✓ ✗ ✓ ✓ ✓
Beneish M-Score
-2.37
Unlikely Manipulator
Ohlson O-Score
-8.39
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A
Score: 71.2/100
Trend: Deteriorating
Earnings Quality
100/100
OCF/NI: 1.18x
Accruals: -1.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. UHS scores 2.99, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. UHS scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. UHS's score of -2.37 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. UHS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. UHS receives an estimated rating of A (score: 71.2/100), with a deteriorating trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). UHS's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
7.10x
PEG
0.26x
P/S
0.50x
P/B
1.39x
P/FCF
10.78x
P/OCF
4.95x
EV/EBITDA
4.98x
EV/Revenue
0.77x
EV/EBIT
6.44x
EV/FCF
16.98x
Earnings Yield
17.12%
FCF Yield
9.28%
Shareholder Yield
12.61%
Graham Number
$267.97
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 7.1x earnings, UHS trades at a deep value multiple. An earnings yield of 17.1% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $267.97 per share, suggesting a potential 51% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.753
NI / EBT
×
Interest Burden
0.930
EBT / EBIT
×
EBIT Margin
0.120
EBIT / Rev
×
Asset Turnover
1.172
Rev / Assets
×
Equity Multiplier
2.126
Assets / Equity
=
ROE
21.0%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. UHS's ROE of 21.0% is driven by Asset Turnover (1.172), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$980.16
Price/Value
0.15x
Margin of Safety
84.83%
Premium
-84.83%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with UHS's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. UHS actually compounded EPS at 37.6% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. At an intrinsic value of $980.16, UHS appears undervalued with a 85% margin of safety. The adjusted fair P/E of 38.5x compares to the current market P/E of 7.1x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$177.49
Median 1Y
$171.26
5th Pctile
$91.59
95th Pctile
$319.42
Ann. Volatility
37.9%
Analyst Target
$196.71
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Marc D. Miller,
Chief Executive Officer and President
$1,430,769 $9,999,904 $16,148,937
Alan B. Miller,
Executive Chairman
$1,073,077 $5,062,102 $8,073,195
Steve G. Filton,
Executive Vice President and Chief Financial Officer
$853,299 $2,450,025 $5,108,695
Edward H. Sim,
Executive Vice President and President, Acute Care (6.)
$802,024 $2,290,465 $4,764,989
Matthew J. Peterson,
Executive Vice President and President, Behavioral Health
$719,971 $2,012,660 $4,176,437

CEO Pay Ratio

199:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $16,148,937
Avg Employee Cost (SGA/emp): $81,111
Employees: 101,500

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
101,500
+2.5% YoY
Revenue / Employee
$171,082
Rev: $17,364,829,000
Profit / Employee
$14,668
NI: $1,488,796,000
SGA / Employee
$81,111
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 17.3% 16.0% 15.1% 12.6% 12.2% 11.2% 11.5% 11.6% 11.3% 11.9% 13.3% 14.9% 16.2% 17.8% 18.4% 18.7% 19.9% 21.4% 21.2% 21.0% 20.99%
ROA 8.2% 7.4% 7.1% 5.9% 5.6% 5.1% 5.1% 5.1% 5.0% 5.2% 5.9% 6.7% 7.3% 8.0% 8.3% 8.7% 9.3% 9.8% 10.0% 9.9% 9.87%
ROIC 11.0% 9.9% 9.5% 7.8% 7.3% 6.9% 7.1% 7.4% 7.4% 7.9% 8.7% 9.9% 10.4% 11.4% 11.5% 11.7% 12.2% 12.1% 12.5% 12.5% 12.46%
ROCE 13.5% 12.4% 11.8% 9.6% 9.2% 8.5% 8.8% 9.1% 9.0% 9.6% 10.6% 11.9% 12.5% 13.7% 14.0% 14.4% 16.2% 16.7% 17.4% 17.2% 17.24%
Gross Margin 88.3% 88.6% 88.7% 89.3% 89.0% 88.9% 89.0% 89.3% 89.4% 89.4% 89.5% 90.1% 90.2% 90.1% 90.2% 90.2% 90.8% 90.6% 90.5% 90.9% 90.87%
Operating Margin 10.0% 9.6% 7.1% 7.0% 8.3% 7.6% 8.0% 7.9% 8.0% 8.9% 10.1% 11.2% 9.7% 11.5% 11.1% 11.7% 11.6% 11.5% 11.2% 11.1% 11.14%
Net Margin 6.9% 7.3% 4.7% 4.9% 5.5% 5.1% 4.7% 4.8% 4.7% 5.8% 6.8% 7.4% 6.5% 8.1% 7.7% 8.2% 8.3% 9.9% 7.8% 7.7% 7.73%
EBITDA Margin 14.0% 14.0% 11.1% 11.4% 12.4% 12.0% 11.7% 11.7% 11.5% 12.9% 13.8% 14.8% 13.5% 15.2% 14.8% 15.4% 15.3% 17.5% 14.7% 14.7% 14.75%
FCF Margin -1.0% 0.2% 3.5% 3.5% 1.8% 2.0% 1.0% 3.7% 2.9% 3.7% 4.0% 5.5% 6.2% 7.1% 6.6% 5.5% 5.6% 4.8% 5.0% 4.6% 4.56%
OCF Margin 5.7% 7.0% 9.7% 9.5% 7.7% 7.4% 6.2% 8.5% 7.9% 8.9% 9.4% 11.3% 12.1% 13.1% 12.6% 11.5% 11.5% 10.7% 10.7% 9.9% 9.94%
ROE 3Y Avg snapshot only 17.55%
ROE 5Y Avg snapshot only 15.47%
ROA 3Y Avg snapshot only 8.21%
ROIC 3Y Avg snapshot only 9.18%
ROIC Economic snapshot only 12.46%
Cash ROA snapshot only 11.30%
Cash ROIC snapshot only 14.25%
CROIC snapshot only 6.54%
NOPAT Margin snapshot only 8.69%
Pretax Margin snapshot only 11.19%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 46.71%
SBC / Revenue snapshot only 0.27%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 10.70 10.23 11.57 9.51 8.58 14.77 13.11 15.97 12.82 14.44 15.20 13.36 15.12 10.49 10.34 9.32 9.65 9.44 7.26 5.84 7.099
P/S Ratio 0.91 0.80 0.84 0.56 0.48 0.74 0.66 0.80 0.62 0.73 0.85 0.83 1.01 0.76 0.77 0.71 0.78 0.81 0.62 0.49 0.500
P/B Ratio 1.80 1.66 1.84 1.27 1.08 1.68 1.49 1.82 1.43 1.69 1.98 1.93 2.35 1.80 1.82 1.67 1.84 1.93 1.47 1.19 1.390
P/FCF -91.07 361.00 24.04 15.94 26.28 38.06 64.73 21.71 21.07 19.75 21.01 14.98 16.22 10.67 11.71 13.03 13.98 16.92 12.35 10.78 10.781
P/OCF 16.09 11.45 8.60 5.93 6.21 10.01 10.66 9.43 7.79 8.17 9.03 7.39 8.34 5.80 6.09 6.18 6.81 7.54 5.79 4.95 4.951
EV/EBITDA 7.58 7.64 8.33 7.47 7.08 9.64 8.77 9.79 8.49 9.13 9.60 8.70 9.68 7.42 7.40 6.85 7.08 7.08 5.74 4.98 4.978
EV/Revenue 1.22 1.15 1.19 0.94 0.86 1.13 1.04 1.17 1.00 1.09 1.20 1.16 1.33 1.06 1.08 1.01 1.08 1.12 0.90 0.77 0.775
EV/EBIT 10.32 10.60 11.83 11.28 10.91 15.32 13.70 15.09 13.01 13.66 13.90 12.18 13.35 10.01 9.90 9.08 9.23 9.14 7.39 6.44 6.442
EV/FCF -122.25 519.52 34.19 26.53 47.38 57.79 101.98 31.73 33.95 29.75 29.80 20.82 21.44 14.97 16.41 18.44 19.24 23.39 17.95 16.98 16.978
Earnings Yield 9.3% 9.8% 8.6% 10.5% 11.6% 6.8% 7.6% 6.3% 7.8% 6.9% 6.6% 7.5% 6.6% 9.5% 9.7% 10.7% 10.4% 10.6% 13.8% 17.1% 17.12%
FCF Yield -1.1% 0.3% 4.2% 6.3% 3.8% 2.6% 1.5% 4.6% 4.7% 5.1% 4.8% 6.7% 6.2% 9.4% 8.5% 7.7% 7.2% 5.9% 8.1% 9.3% 9.28%
PEG Ratio snapshot only 0.257
Price/Tangible Book snapshot only 2.523
EV/OCF snapshot only 7.796
EV/Gross Profit snapshot only 0.854
Acquirers Multiple snapshot only 6.819
Shareholder Yield snapshot only 12.61%
Graham Number snapshot only $267.97
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.19 1.14 1.07 1.22 1.27 1.33 1.37 1.29 1.38 1.40 1.38 1.28 1.39 1.27 1.32 1.29 1.03 1.05 1.08 1.12 1.116
Quick Ratio 1.09 1.04 0.98 1.12 1.15 1.21 1.26 1.18 1.28 1.29 1.28 1.17 1.28 1.17 1.23 1.19 0.96 0.98 1.01 1.04 1.045
Debt/Equity 0.65 0.75 0.80 0.86 0.88 0.89 0.88 0.85 0.89 0.87 0.85 0.77 0.77 0.74 0.75 0.71 0.71 0.76 0.68 0.70 0.700
Net Debt/Equity 0.62 0.73 0.78 0.84 0.87 0.87 0.86 0.84 0.87 0.85 0.83 0.75 0.76 0.72 0.73 0.69 0.69 0.74 0.66 0.68 0.682
Debt/Assets 0.32 0.35 0.36 0.38 0.39 0.39 0.39 0.38 0.39 0.38 0.38 0.36 0.36 0.34 0.34 0.33 0.33 0.35 0.33 0.33 0.330
Debt/EBITDA 2.03 2.39 2.53 3.06 3.20 3.36 3.27 3.14 3.27 3.14 2.89 2.50 2.41 2.19 2.17 2.06 1.98 2.01 1.83 1.87 1.866
Net Debt/EBITDA 1.93 2.33 2.47 2.98 3.15 3.29 3.20 3.09 3.22 3.07 2.83 2.44 2.36 2.13 2.12 2.01 1.94 1.96 1.79 1.82 1.817
Interest Coverage 17.15 16.71 15.88 12.66 10.36 7.79 6.61 5.96 5.45 5.52 6.05 6.80 7.64 8.96 10.02 11.43 12.89 13.63 14.34 13.90 13.896
Equity Multiplier 2.05 2.15 2.24 2.29 2.28 2.28 2.25 2.26 2.29 2.27 2.24 2.17 2.17 2.17 2.19 2.13 2.12 2.19 2.08 2.12 2.121
Cash Ratio snapshot only 0.042
Debt Service Coverage snapshot only 17.986
Cash to Debt snapshot only 0.026
FCF to Debt snapshot only 0.157
Defensive Interval snapshot only 74.7 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.96 0.95 0.98 1.00 1.01 1.01 1.02 1.02 1.03 1.04 1.06 1.08 1.09 1.11 1.11 1.13 1.14 1.14 1.16 1.17 1.172
Inventory Turnover 7.41 7.18 7.21 7.25 6.97 6.93 6.99 7.10 7.03 7.04 7.20 7.21 7.25 7.25 7.25 7.33 7.35 7.32 7.46 7.39 7.386
Receivables Turnover 7.54 7.27 7.55 7.20 7.22 7.12 7.17 7.01 6.78 6.71 6.77 7.05 6.93 7.17 6.83 7.38 7.08 7.27 6.89 7.10 7.099
Payables Turnover 0.82 2.32 0.77 0.81 0.81 2.28 0.82 0.81 0.85 2.45 0.90 0.83 0.86 2.55 0.81 0.78 0.78 2.40 0.76 0.73 0.726
DSO 48 50 48 51 51 51 51 52 54 54 54 52 53 51 53 49 52 50 53 51 51.4 days
DIO 49 51 51 50 52 53 52 51 52 52 51 51 50 50 50 50 50 50 49 49 49.4 days
DPO 447 157 472 451 453 160 444 448 429 149 406 440 426 143 451 465 470 152 483 503 502.9 days
Cash Conversion Cycle -349 -56 -373 -350 -350 -56 -341 -345 -324 -43 -302 -337 -323 -42 -347 -366 -369 -52 -381 -402 -402.0 days
Fixed Asset Turnover snapshot only 2.413
Operating Cycle snapshot only 100.8 days
Cash Velocity snapshot only 130.508
Capital Intensity snapshot only 0.880
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 9.5% 9.4% 10.0% 6.9% 6.2% 6.0% 5.0% 5.8% 6.0% 6.6% 8.0% 8.8% 9.9% 10.8% 9.7% 9.6% 10.2% 9.7% 10.4% 10.0% 10.05%
Net Income 20.6% 5.2% -7.3% -28.4% -30.2% -31.8% -26.8% -10.6% -8.5% 6.3% 19.3% 35.0% 51.7% 59.1% 46.6% 35.0% 34.0% 30.4% 27.1% 21.0% 21.02%
EPS 22.9% 13.0% 4.6% -17.6% -20.1% -24.3% -22.1% -6.1% -4.0% 11.4% 24.5% 40.8% 55.1% 62.6% 52.0% 41.0% 40.5% 35.6% 36.1% 31.2% 31.21%
FCF -1.1% -98.3% -60.3% 1.7% 2.9% 8.3% -69.2% 10.1% 70.5% 1.0% 3.3% 63.8% 1.3% 1.1% 78.9% 8.2% -0.8% -26.1% -15.4% -8.3% -8.30%
EBITDA 11.7% 2.2% -5.0% -19.4% -19.5% -17.7% -12.7% 0.4% 1.8% 8.9% 13.8% 21.0% 28.9% 32.4% 27.8% 21.6% 21.7% 21.1% 19.3% 16.2% 16.20%
Op. Income 13.9% 0.3% -8.3% -26.9% -27.9% -26.4% -19.3% 0.1% 4.7% 17.1% 22.5% 31.5% 39.3% 43.1% 36.0% 25.7% 26.5% 18.6% 16.8% 13.6% 13.62%
OCF Growth snapshot only -5.27%
Asset Growth snapshot only 6.34%
Equity Growth snapshot only 6.88%
Debt Growth snapshot only 5.08%
Shares Change snapshot only -7.77%
Dividend Growth snapshot only 1.89%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 5.3% 5.5% 5.9% 5.7% 5.6% 5.6% 6.0% 7.0% 7.3% 7.3% 7.7% 7.1% 7.4% 7.8% 7.6% 8.1% 8.7% 9.0% 9.4% 9.5% 9.50%
Revenue 5Y 5.3% 5.3% 5.4% 5.2% 5.2% 5.2% 5.3% 5.5% 5.6% 5.8% 6.1% 6.3% 6.5% 6.8% 7.1% 7.9% 8.4% 8.5% 8.6% 8.2% 8.21%
EPS 3Y 12.0% 13.9% 12.3% 5.1% 7.2% 0.4% 4.7% 4.2% -1.9% -1.6% 0.5% 2.9% 6.0% 11.1% 13.8% 23.1% 27.9% 34.9% 37.1% 37.6% 37.62%
EPS 5Y 12.1% 11.6% 10.8% 7.1% 6.6% 3.5% 3.3% 2.6% 1.5% 4.5% 6.6% 8.9% 12.9% 12.9% 16.8% 17.6% 15.5% 16.0% 16.0% 15.1% 15.06%
Net Income 3Y 8.0% 8.3% 5.8% -1.1% 0.6% -6.0% -1.7% -2.0% -8.3% -8.6% -6.8% -4.7% -1.0% 4.9% 8.6% 17.7% 23.0% 30.2% 30.5% 30.2% 30.17%
Net Income 5Y 8.6% 7.1% 5.4% 1.5% 0.9% -2.1% -2.3% -3.1% -4.3% -1.6% 0.7% 3.1% 7.2% 7.0% 10.7% 11.4% 9.4% 9.6% 8.6% 7.1% 7.14%
EBITDA 3Y 5.2% 5.1% 3.7% -0.7% 0.4% -3.0% 0.0% 0.5% -2.9% -2.9% -1.9% -0.7% 1.9% 5.9% 8.3% 13.9% 16.9% 20.4% 20.2% 19.6% 19.57%
EBITDA 5Y 3.6% 2.6% 1.8% -0.6% -0.8% -1.8% -1.1% -0.7% -1.0% 0.8% 2.1% 3.5% 5.8% 5.7% 7.8% 8.4% 7.5% 8.0% 7.6% 6.7% 6.71%
Gross Profit 3Y 5.1% 5.3% 5.7% 5.5% 5.5% 5.6% 6.0% 7.0% 7.4% 7.5% 7.9% 7.5% 7.8% 8.3% 8.1% 8.6% 9.3% 9.6% 10.0% 10.2% 10.15%
Gross Profit 5Y 5.2% 5.1% 5.3% 5.1% 5.1% 5.1% 5.2% 5.5% 5.6% 5.8% 6.2% 6.4% 6.7% 7.1% 7.4% 8.1% 8.7% 8.9% 9.1% 8.7% 8.67%
Op. Income 3Y 5.3% 5.1% 3.2% -3.1% -2.4% -6.2% -1.9% -0.9% -4.9% -4.7% -3.2% -1.3% 1.7% 7.3% 10.4% 18.3% 22.7% 25.7% 24.8% 23.4% 23.38%
Op. Income 5Y 2.6% 1.2% 0.3% -3.0% -3.4% -4.8% -3.6% -2.7% -2.5% 0.0% 1.7% 3.7% 6.3% 6.7% 9.5% 10.0% 8.7% 8.0% 7.6% 6.6% 6.56%
FCF 3Y — -62.4% -8.9% -8.4% -31.8% -30.3% -46.0% -31.5% -39.8% -31.4% -19.5% 70.0% — 2.4% 32.9% 25.0% 57.9% 46.9% 86.2% 17.5% 17.55%
FCF 5Y — -26.8% 28.7% — — -14.5% -19.4% -1.7% -3.0% -0.2% -0.2% 6.7% 4.7% 7.7% 3.7% -10.6% -12.9% -12.6% -4.6% 37.3% 37.27%
OCF 3Y -18.1% -13.0% -2.8% -2.4% -10.3% -11.5% -18.4% -19.7% -24.7% -18.7% -10.7% 18.0% 38.3% 32.7% 17.3% 15.2% 24.0% 23.2% 31.3% 15.4% 15.39%
OCF 5Y -11.9% -7.3% -0.8% 4.0% -0.9% -3.4% -4.6% -1.7% -2.8% -1.1% 0.1% 4.8% 5.6% 7.5% 5.6% -3.5% -5.7% -4.6% -0.2% 11.9% 11.85%
Assets 3Y 4.5% 5.1% 3.9% 4.2% 4.9% 5.0% 5.3% 4.2% 2.3% 1.2% 2.4% 3.2% 3.8% 3.4% 4.2% 4.1% 4.7% 5.7% 5.0% 5.1% 5.08%
Assets 5Y 5.8% 4.9% 4.7% 4.7% 4.7% 4.6% 4.2% 4.4% 4.2% 4.4% 3.7% 3.7% 4.4% 4.4% 5.1% 4.3% 3.4% 3.4% 3.7% 4.5% 4.46%
Equity 3Y 5.4% 4.2% 2.3% 2.5% 2.8% 2.5% 3.6% 2.3% 0.6% -0.9% -1.3% 0.0% 1.7% 3.1% 5.0% 6.5% 7.3% 7.1% 7.8% 7.3% 7.27%
Book Value 3Y 9.3% 9.6% 8.6% 8.9% 9.5% 9.5% 10.3% 8.7% 7.6% 6.7% 6.4% 8.1% 9.0% 9.1% 10.0% 11.5% 11.6% 11.0% 13.2% 13.4% 13.41%
Dividend 3Y 17.3% 64.1% 64.9% 29.8% 12.9% 2.7% 3.1% 3.6% 4.8% 5.8% 6.0% 6.2% 5.6% 4.5% 3.8% 3.7% 2.8% 2.3% 3.3% 3.6% 3.56%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.96 0.97 0.96 0.95 0.94 0.95 0.95 0.97 0.96 0.97 0.97 0.98 0.97 0.96 0.97 0.98 0.98 0.98 0.98 0.97 0.973
Earnings Stability 0.71 0.94 0.59 0.17 0.15 0.03 0.02 0.02 0.05 0.08 0.00 0.01 0.04 0.04 0.19 0.25 0.24 0.33 0.39 0.45 0.450
Margin Stability 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.991
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.92 0.98 0.97 0.89 0.88 0.87 0.89 0.96 0.97 0.97 0.92 0.86 0.50 0.50 0.81 0.86 0.86 0.88 0.89 0.92 0.916
Earnings Smoothness 0.81 0.95 0.92 0.67 0.64 0.62 0.69 0.89 0.91 0.94 0.82 0.70 0.59 0.54 0.62 0.70 0.71 0.74 0.76 0.81 0.810
ROE Trend 0.03 0.01 0.02 -0.01 -0.03 -0.04 -0.04 -0.04 -0.04 -0.02 -0.01 0.02 0.04 0.06 0.05 0.05 0.06 0.06 0.05 0.04 0.041
Gross Margin Trend -0.00 -0.00 -0.00 -0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.008
FCF Margin Trend -0.13 -0.10 -0.05 -0.04 -0.06 -0.05 -0.06 0.01 0.03 0.03 0.02 0.02 0.04 0.04 0.04 0.01 0.01 -0.01 -0.00 -0.01 -0.009
Sustainable Growth Rate 16.5% 14.9% 14.1% 11.6% 11.2% 10.3% 10.6% 10.7% 10.4% 11.0% 12.4% 14.0% 15.3% 17.0% 17.5% 17.9% 19.1% 20.6% 20.5% 20.3% 20.30%
Internal Growth Rate 8.5% 7.5% 7.1% 5.8% 5.5% 4.9% 4.9% 4.9% 4.8% 5.1% 5.8% 6.8% 7.4% 8.3% 8.6% 9.1% 9.8% 10.4% 10.6% 10.6% 10.56%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.66 0.89 1.35 1.60 1.38 1.48 1.23 1.69 1.65 1.77 1.68 1.81 1.81 1.81 1.70 1.51 1.42 1.25 1.25 1.18 1.180
FCF/OCF -0.18 0.03 0.36 0.37 0.24 0.26 0.16 0.43 0.37 0.41 0.43 0.49 0.51 0.54 0.52 0.47 0.49 0.45 0.47 0.46 0.459
FCF/Net Income snapshot only 0.542
OCF/EBITDA snapshot only 0.638
CapEx/Revenue 6.6% 6.8% 6.2% 6.0% 5.9% 5.5% 5.2% 4.8% 5.0% 5.2% 5.3% 5.7% 5.9% 6.0% 6.1% 6.1% 5.9% 6.0% 5.7% 5.4% 5.37%
CapEx/Depreciation snapshot only 1.518
Accruals Ratio 0.03 0.01 -0.02 -0.04 -0.02 -0.02 -0.01 -0.04 -0.03 -0.04 -0.04 -0.05 -0.06 -0.07 -0.06 -0.04 -0.04 -0.02 -0.03 -0.02 -0.018
Sloan Accruals snapshot only -0.060
Cash Flow Adequacy snapshot only 1.760
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.4% 0.7% 0.6% 0.8% 0.9% 0.6% 0.6% 0.5% 0.6% 0.5% 0.4% 0.4% 0.3% 0.4% 0.4% 0.4% 0.4% 0.4% 0.5% 0.6% 0.46%
Dividend/Share $0.60 $0.83 $0.84 $0.83 $0.82 $0.81 $0.81 $0.81 $0.81 $0.81 $0.80 $0.80 $0.79 $0.80 $0.81 $0.81 $0.80 $0.80 $0.82 $0.83 $0.80
Payout Ratio 4.8% 6.7% 6.8% 8.0% 8.1% 8.7% 8.4% 8.2% 8.3% 7.7% 6.7% 5.8% 5.2% 4.7% 4.5% 4.2% 3.8% 3.4% 3.3% 3.2% 3.25%
FCF Payout Ratio — 2.4% 14.2% 13.3% 24.8% 22.3% 41.7% 11.2% 13.7% 10.6% 9.3% 6.5% 5.6% 4.7% 5.0% 5.9% 5.5% 6.2% 5.7% 6.0% 6.00%
Total Payout Ratio 78.2% 1.3% 1.8% 1.9% 1.7% 1.3% 89.2% 77.3% 81.5% 84.0% 80.7% 67.4% 62.0% 63.4% 67.3% 68.5% 66.8% 68.5% 63.1% 73.6% 73.63%
Div. Increase Streak 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Chowder Number 0.45 2.81 2.75 0.83 0.20 -0.11 -0.09 -0.07 -0.05 -0.05 -0.05 -0.05 -0.04 -0.03 -0.02 -0.02 -0.03 -0.04 -0.04 -0.05 -0.055
Buyback Yield 6.9% 12.1% 14.6% 19.3% 18.5% 8.4% 6.2% 4.3% 5.7% 5.3% 4.9% 4.6% 3.8% 5.6% 6.1% 6.9% 6.5% 6.9% 8.2% 12.1% 12.05%
Net Buyback Yield 6.7% 11.9% 14.5% 19.1% 18.3% 8.2% 6.0% 4.2% 5.6% 5.1% 4.8% 4.5% 3.7% 5.5% 6.0% 6.8% 6.4% 6.8% 8.1% 11.9% 11.86%
Total Shareholder Return 7.2% 12.6% 15.1% 19.9% 19.2% 8.8% 6.7% 4.7% 6.2% 5.7% 5.2% 4.9% 4.0% 5.9% 6.4% 7.2% 6.8% 7.1% 8.5% 12.4% 12.41%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.76 0.77 0.77 0.77 0.78 0.78 0.78 0.77 0.77 0.76 0.77 0.77 0.77 0.76 0.76 0.75 0.75 0.75 0.75 0.75 0.753
Interest Burden (EBT/EBIT) 0.94 0.94 0.94 0.92 0.91 0.88 0.85 0.84 0.82 0.82 0.84 0.86 0.87 0.89 0.90 0.91 0.92 0.93 0.93 0.93 0.930
EBIT Margin 0.12 0.11 0.10 0.08 0.08 0.07 0.08 0.08 0.08 0.08 0.09 0.09 0.10 0.11 0.11 0.11 0.12 0.12 0.12 0.12 0.120
Asset Turnover 0.96 0.95 0.98 1.00 1.01 1.01 1.02 1.02 1.03 1.04 1.06 1.08 1.09 1.11 1.11 1.13 1.14 1.14 1.16 1.17 1.172
Equity Multiplier 2.11 2.14 2.12 2.12 2.16 2.21 2.25 2.27 2.29 2.28 2.25 2.21 2.23 2.22 2.22 2.15 2.15 2.18 2.13 2.13 2.126
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $12.65 $12.42 $12.29 $10.40 $10.11 $9.40 $9.57 $9.77 $9.71 $10.47 $11.92 $13.76 $15.07 $17.03 $18.13 $19.40 $21.16 $23.10 $24.66 $25.46 $25.46
Book Value/Share $74.98 $76.43 $77.17 $78.12 $80.14 $82.47 $84.10 $85.93 $87.11 $89.70 $91.36 $95.49 $96.99 $99.39 $102.75 $108.17 $111.25 $112.87 $122.12 $125.35 $128.35
Tangible Book/Share $28.50 $26.70 $25.22 $25.56 $27.12 $28.01 $29.35 $30.46 $30.92 $32.34 $34.00 $37.44 $38.76 $39.61 $42.97 $46.96 $49.87 $49.79 $57.57 $58.93 $58.93
Revenue/Share $148.84 $158.67 $169.94 $175.29 $181.05 $186.64 $189.88 $194.79 $201.45 $208.34 $214.04 $221.11 $226.37 $235.98 $243.56 $253.27 $261.46 $269.38 $288.00 $302.21 $303.72
FCF/Share $-1.49 $0.35 $5.91 $6.21 $3.30 $3.65 $1.94 $7.18 $5.91 $7.65 $8.62 $12.27 $14.05 $16.75 $16.00 $13.87 $14.61 $12.88 $14.50 $13.79 $13.86
OCF/Share $8.41 $11.09 $16.53 $16.69 $13.97 $13.87 $11.77 $16.54 $15.98 $18.49 $20.06 $24.88 $27.33 $30.82 $30.75 $29.24 $29.98 $28.92 $30.91 $30.03 $30.19
Cash/Share $2.27 $1.45 $1.39 $1.78 $1.02 $1.43 $1.54 $1.12 $1.16 $1.74 $1.64 $1.90 $1.56 $1.88 $1.92 $2.12 $1.74 $2.14 $1.93 $2.32 $2.33
EBITDA/Share $23.98 $23.94 $24.27 $22.07 $22.11 $21.88 $22.54 $23.29 $23.63 $24.96 $26.78 $29.38 $31.13 $33.77 $35.50 $37.34 $39.71 $42.55 $45.33 $47.04 $47.04
Debt/Share $48.59 $57.22 $61.42 $67.57 $70.73 $73.42 $73.76 $73.09 $77.33 $78.29 $77.50 $73.55 $74.98 $73.88 $77.14 $77.06 $78.64 $85.43 $83.12 $87.79 $87.79
Net Debt/Share $46.32 $55.78 $60.03 $65.78 $69.71 $71.99 $72.23 $71.97 $76.17 $76.55 $75.86 $71.66 $73.42 $72.00 $75.22 $74.94 $76.90 $83.30 $81.19 $85.47 $85.47
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.989
Altman Z-Prime snapshot only 3.897
Piotroski F-Score 6 5 6 6 7 7 7 7 7 9 9 8 9 8 8 9 8 7 8 8 8
Beneish M-Score -2.22 -2.43 -2.55 -2.64 -2.52 -2.46 -2.39 -2.51 -2.47 -2.57 -2.55 -2.71 -2.74 -2.79 -2.69 -2.61 -2.51 -2.39 -3.01 -2.37 -2.373
Ohlson O-Score snapshot only -8.389
ROIC (Greenblatt) snapshot only 27.61%
Net-Net WC snapshot only $-76.76
EVA snapshot only $310881500.15
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A
Credit Score 70.39 66.94 66.80 67.45 61.37 63.98 61.62 62.37 62.38 61.86 69.77 69.68 71.92 73.66 75.56 76.25 69.72 72.94 66.52 71.23 71.233
Credit Grade snapshot only 6
Credit Trend snapshot only -5.021
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 63
Sector Credit Rank snapshot only 68

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms